Date: 2017-08-04
Type of information: Company acquisition
Company: Lonza (Switzerland)
Investors:
Amount: € 700 million and $ 200 million
Funding type: private placement
Planned used:
- The proceeds of the “Schuldschein” loan will be used for the
refinancing of the Capsugel acquisition.
Others:
- • On August 4, 2017, Lonza announced the pricing of its multitranche "Schuldschein" loan (private placement) with a total size of € 700 million and $ 200 million at competitive
market terms. The EUR tranches have maturities of 4 and 6
years respectively with fixed and variable coupons. The
USD tranches have maturities of 5 (variable coupon) and 7
years (fixed coupon).
Commerzbank, Helaba, HSBC, ING Bank, and LBBW have jointly acted as arrangers of the “Schuldschein” loan.
Therapeutic area: Technology - Services
Is general: Yes
